Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Completed Phase 1 Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00357305Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersTreatment